Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Waverley Pharma Inc V.WAVE

Waverley Pharma Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of human therapeutics focused on oncology. The Company is focused on the generic oncology injectable market in Europe, the United Kingdom (UK), and North America. The Company, through its subsidiaries, has entered into a license, manufacture, supply, marketing and distribution... see more

TSXV:WAVE - Post Discussion

Waverley Pharma Inc > How much is Pemetrexed and Bortezomib?
View:
Post by Res3archGuru on Aug 28, 2020 6:43am

How much is Pemetrexed and Bortezomib?

Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy


"Pemetrexed is an injectable chemotherapy product used in the treatment of pleural mesothelioma and non-small cell lung cancer along with other indications. The Company has obtained marketing authorization for this product in numerous countries and is in the process of filing for market authorization in additional countries across Europe".

Bortezomib is an injectable chemotherapy product used to treat multiple myeloma and mantle cell lymphoma along with other indications. The Company has obtained marketing authorization for this product in numerous countries and is in the process of filing for market authorization in additional countries across Europe.

Pemetrexed, sold under the brand name Alimta among others, is a chemotherapy medication for the treatment of pleural mesothelioma and non-small cell lung cancer (NSCLC).

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection

How much should I expect to pay for Alimta? $9863.60 per month. 

The cost for Velcade injectable powder for injection 3.5 mg is around $1,683 for a supply of 1 powder for injection, depending on the pharmacy you visit. 

https://www.bloomberg.com/graphics/2016-drug-prices/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2500250/
https://www.lillypricinginfo.com/alimta
https://www.drugs.com/price-guide/velcade#:~:text=The%20cost%20for%20Velcade%20injectable,not%20valid%20with%20insurance%20plans.
Be the first to comment on this post